+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Self Testing - Medical Devices Pipeline Assessment, 2020

  • PDF Icon

    Report

  • 61 Pages
  • August 2020
  • Region: Global
  • GlobalData
  • ID: 5138846
Self Testing - Medical Devices Pipeline Assessment, 2020

Summary

The publisher's Medical Devices sector report, “Self Testing - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Self Testing pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Self Testing Devices are diagnostic devices enables an individual to diagnose health at home and helps to monitor disease condition using patient’s sample.


Note:
Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Self Testing Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Self Testing Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Self Testing Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents2 Introduction
3 Products under Development
3.1 Self Testing - Pipeline Products by Stage of Development
3.2 Self Testing - Pipeline Products by Territory
3.3 Self Testing - Pipeline Products by Regulatory Path
3.4 Self Testing - Pipeline Products by Estimated Approval Date
3.5 Self Testing - Ongoing Clinical Trials
4 Self Testing - Pipeline Products under Development by Companies
4.1 Self Testing Companies - Pipeline Products by Stage of Development
4.2 Self Testing - Pipeline Products by Stage of Development
5 Self Testing Companies and Product Overview
5.1 bioLytical Laboratories Inc Company Overview
5.2 Boston Microfluidics Company Overview
5.3 Brigham and Women's Hospital Company Overview
5.4 Emory University Company Overview
5.5 Entia Ltd Company Overview
5.6 InnaMed Inc Company Overview
5.7 Module Innovations Pvt Ltd Company Overview
5.8 Morgan Innovation And Technology Ltd Company Overview
5.9 Novosanis NV Company Overview
5.10 OncoGenesis Company Overview
5.11 Premier Medical Corporation Company Overview
5.12 Shanghai Kehua Bio-engineering Co Ltd Company Overview
5.13 Svenska Cellulosa Aktiebolaget Company Overview
5.14 Tasso, Inc. Company Overview
5.15 University of Washington Company Overview
5.16 Wellmetrix LLC Company Overview
6 Self Testing- Recent Developments7 Appendix
List of Tables
Table 1: Self Testing - Pipeline Products by Stage of Development
Table 2: Self Testing - Pipeline Products by Territory
Table 3: Self Testing - Pipeline Products by Regulatory Path
Table 4: Self Testing - Pipeline Products by Estimated Approval Date
Table 5: Self Testing - Ongoing Clinical Trials
Table 6: Self Testing Companies - Pipeline Products by Stage of Development
Table 7: Self Testing - Pipeline Products by Stage of Development
Table 8: bioLytical Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: INSTI HIV Self Test - Product Status
Table 10: INSTI HIV Self Test - Product Description
Table 11: Boston Microfluidics Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Knownow - Product Status
Table 13: Knownow - Product Description
Table 14: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Smartphone Ovulation Test - Product Status
Table 16: Smartphone Ovulation Test - Product Description
Table 17: Emory University Pipeline Products & Ongoing Clinical Trials Overview
Table 18: PrEP@Home - HIV Testing Kit - Product Status
Table 19: PrEP@Home - HIV Testing Kit - Product Description
Table 20: Emory University - Ongoing Clinical Trials Overview
Table 21: PrEP@Home - HIV Testing Kit - Making it Last: A Randomized, Controlled Trial of a Home Care System to Promote Persistence in PrEP Care
Table 22: Entia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Affinity - Product Status
Table 24: Affinity - Product Description
Table 25: Entia Ltd - Ongoing Clinical Trials Overview
Table 26: Affinity - Affinity: Hospital Trial. Early Prototype Testing for a Home Oncology Monitoring System
Table 27: InnaMed Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 28: TeleHeart - Product Status
Table 29: TeleHeart - Product Description
Table 30: TeleKidney - Product Status
Table 31: TeleKidney - Product Description
Table 32: TeleLab - Fertility And IVF - Product Status
Table 33: TeleLab - Fertility And IVF - Product Description
Table 34: TeleLab - Metabolic Disorders - Product Status
Table 35: TeleLab - Metabolic Disorders - Product Description
Table 36: TeleLab - Post Organ Transplant - Product Status
Table 37: TeleLab - Post Organ Transplant - Product Description
Table 38: Module Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 39: EcoSense - Product Status
Table 40: EcoSense - Product Description
List of Figures
Figure 1: Self Testing - Pipeline Products by Stage of Development
Figure 2: Self Testing - Pipeline Products by Territory
Figure 3: Self Testing - Pipeline Products by Regulatory Path
Figure 4: Self Testing - Pipeline Products by Estimated Approval Date
Figure 5: Self Testing - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • bioLytical Laboratories Inc
  • Boston Microfluidics
  • Brigham and Women's Hospital
  • Emory University
  • Entia Ltd
  • InnaMed Inc
  • Module Innovations Pvt Ltd
  • Morgan Innovation And Technology Ltd
  • Novosanis NV
  • OncoGenesis
  • Premier Medical Corporation
  • Shanghai Kehua Bio-engineering Co Ltd
  • Svenska Cellulosa Aktiebolaget
  • Tasso, Inc.
  • University of Washington
  • Wellmetrix LLC